Stewart, J. P., Sandall, C. M., Parriott, J. E., Curran, S. M., McCulloh, R. J., Ronning, D. R., . . . Vetro, J. A. Early-Stage IM Treatment with the Host-Derived Immunostimulant CPDI-02 Increases Curative Protection of Healthy Outbred Mice Against Subcutaneous Infection with Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> USA300. MDPI AG.
Chicago Style (17th ed.) CitationStewart, Jason P., et al. Early-Stage IM Treatment with the Host-Derived Immunostimulant CPDI-02 Increases Curative Protection of Healthy Outbred Mice Against Subcutaneous Infection with Community-Acquired Methicillin-Resistant <i>Staphylococcus Aureus</i> USA300. MDPI AG.
MLA (9th ed.) CitationStewart, Jason P., et al. Early-Stage IM Treatment with the Host-Derived Immunostimulant CPDI-02 Increases Curative Protection of Healthy Outbred Mice Against Subcutaneous Infection with Community-Acquired Methicillin-Resistant <i>Staphylococcus Aureus</i> USA300. MDPI AG.